Abaxis Company Profile (NASDAQ:ABAX)

About Abaxis

Abaxis logoAbaxis, Inc. is a developer, manufacturer and marketer of portable blood analysis systems that are used in medical specialties in human or veterinary patient care to provide clinicians with blood constituent measurements. The Company markets and sells its products around the world through independent distributors and direct sales force. The Company's segments are the medical market and the veterinary market. The Company's medical market products include Piccolo chemistry analyzers and consumable products. The Company develops, manufactures and sells the Piccolo Xpress chemistry analyzer for use in human patient care to provide clinicians with blood constituent measurements. The Company's veterinary market product offerings include VetScan chemistry analyzers and veterinary reagent discs, VetScan hematology instruments and related reagent kits, VetScan VSpro specialty analyzers and related consumables, VetScan i-STAT analyzers and related consumables and VetScan rapid tests.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: ABAX
  • CUSIP: 00256710
Key Metrics:
  • Previous Close: $50.12
  • 50 Day Moving Average: $49.97
  • 200 Day Moving Average: $50.69
  • 52-Week Range: $37.85 - $55.95
  • Trailing P/E Ratio: 33.40
  • Foreward P/E Ratio: 36.09
  • P/E Growth: 3.92
  • Market Cap: $1.12B
  • Outstanding Shares: 22,540,000
  • Beta: 0.88
  • Net Margins: 15.06%
  • Return on Equity: 12.02%
  • Return on Assets: 10.52%
  • Current Ratio: 7.74%
  • Quick Ratio: 6.38%
Additional Links:
Companies Related to Abaxis:

Analyst Ratings

Consensus Ratings for Abaxis (NASDAQ:ABAX) (?)
Ratings Breakdown: 2 Sell Ratings, 4 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 1.86)
Consensus Price Target: $45.00 (9.64% downside)

Analysts' Ratings History for Abaxis (NASDAQ:ABAX)
DateFirmActionRatingPrice TargetDetails
2/14/2017Canaccord GenuityReiterated RatingHold$48.00View Rating Details
2/1/2017Seaport Global SecuritiesUpgradeBuyView Rating Details
1/27/2017Stifel NicolausLower Price TargetHold$50.00 -> $48.00View Rating Details
11/30/2016Northcoast ResearchDowngradeBuy -> NeutralView Rating Details
8/16/2016Credit Suisse GroupReiterated RatingSell$39.00View Rating Details
7/22/2016Feltl & Co.DowngradeHold -> SellView Rating Details
4/1/2016CL KingInitiated CoverageNeutralView Rating Details
1/29/2016Piper Jaffray CompaniesLower Price TargetNeutral$49.00 -> $45.00View Rating Details
10/21/2015Bank of America CorpDowngradeNeutral -> Underperform$66.00 -> $39.00View Rating Details
(Data available from 2/23/2015 forward)


Earnings History for Abaxis (NASDAQ:ABAX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/26/2017Q317$0.31$0.30$54.36 million$52.80 millionViewN/AView Earnings Details
10/25/2016Q217$0.35$0.34$60.69 million$58.60 millionViewListenView Earnings Details
7/21/2016Q117$0.32$0.30$58.70 million$57.70 millionViewListenView Earnings Details
4/28/2016Q416$0.32$0.36$56.62 million$57.00 millionViewListenView Earnings Details
1/28/2016Q316$0.33$0.35$58.52 million$52.90 millionViewListenView Earnings Details
10/27/2015Q216$0.32$0.34$56.20 million$56.00 millionViewListenView Earnings Details
7/23/2015Q116$0.28$0.31$53.75 million$53.10 millionViewListenView Earnings Details
4/30/2015Q415$0.27$0.17$55.62 million$52.00 millionViewN/AView Earnings Details
1/29/2015Q315$0.25$0.26$51.70 million$59.50 millionViewN/AView Earnings Details
10/21/2014Q215$0.23$0.39$50.55 million$53.90 millionViewListenView Earnings Details
7/24/2014Q115$0.19$0.21$46.95 million$47.50 millionViewN/AView Earnings Details
4/24/2014Q414$0.19$0.17$45.74 million$42.04 millionViewN/AView Earnings Details
1/31/2014Q314$0.20$0.14$49.47 million$40.00 millionViewN/AView Earnings Details
10/22/2013Q114$0.21$0.18$48.60 million$45.90 millionViewN/AView Earnings Details
7/25/2013Q1 2014$0.23$0.14$49.13 million$43.20 millionViewListenView Earnings Details
4/25/2013Q4 2013$0.26$0.30$52.47 million$50.00 millionViewListenView Earnings Details
1/31/2013Q3 2013$0.20$0.22$45.75 million$49.80 millionViewListenView Earnings Details
10/23/2012$0.18$0.18ViewN/AView Earnings Details
7/26/2012$0.17$0.13ViewN/AView Earnings Details
4/26/2012$0.16$0.21ViewN/AView Earnings Details
1/26/2012$0.16$0.13ViewN/AView Earnings Details
10/25/2011$0.14$0.15ViewN/AView Earnings Details
7/28/2011$0.16$0.10ViewN/AView Earnings Details
4/28/2011$0.16$0.15ViewN/AView Earnings Details
1/27/2011$0.18$0.17ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Abaxis (NASDAQ:ABAX)
Current Year EPS Consensus Estimate: $1.28 EPS
Next Year EPS Consensus Estimate: $1.38 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$0.27$0.35$0.31
Q2 20162$0.39$0.40$0.40
Q3 20163$0.42$0.44$0.43
Q4 20161$0.39$0.39$0.39
Q1 20171$0.34$0.34$0.34
Q2 20171$0.34$0.34$0.34
Q3 20172$0.29$0.32$0.31
Q4 20172$0.27$0.33$0.30
Q1 20181$0.33$0.33$0.33
Q2 20181$0.38$0.38$0.38
Q3 20181$0.31$0.31$0.31
Q4 20181$0.37$0.37$0.37
(Data provided by Zacks Investment Research)


Current Dividend Information for Abaxis (NASDAQ:ABAX)
Annual Dividend:$0.56
Dividend Yield:1.12%
Payout Ratio:37.58% (Based on Trailing 12 Months of Earnings)
43.75% (Based on Current Year Consensus EPS Estimate)
40.58% (Based on Next Year Consensus EPS Estimate)

Dividend History for Abaxis (NASDAQ:ABAX)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Abaxis (NASDAQ:ABAX)
Insider Ownership Percentage: 4.10%
Institutional Ownership Percentage: 98.44%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/2/2017Richard BastianiDirectorSell4,000$51.12$204,480.00View SEC Filing  
12/6/2016Clinton SeversonCEOSell15,000$51.35$770,250.00View SEC Filing  
12/2/2016Kenneth AronInsiderSell5,000$51.09$255,450.00View SEC Filing  
9/9/2016Clinton SeversonCEOSell2,000$48.29$96,580.00View SEC Filing  
9/8/2016Prithipal SinghDirectorSell1,000$49.50$49,500.00View SEC Filing  
8/25/2016Prithipal SinghDirectorSell1,500$50.30$75,450.00View SEC Filing  
8/24/2016Donald Peter WoodInsiderSell8,500$50.21$426,785.00View SEC Filing  
6/9/2016Richard BastianiDirectorSell5,000$46.75$233,750.00View SEC Filing  
5/17/2016Achim HenkelDirectorSell5,000$44.43$222,150.00View SEC Filing  
5/9/2016Henk EvenhuisDirectorSell3,000$45.00$135,000.00View SEC Filing  
2/9/2016Vernon E AltmanDirectorBuy303$39.87$12,080.61View SEC Filing  
12/8/2015Craig TockmanVPSell560$54.44$30,486.40View SEC Filing  
2/9/2015Prithipal SinghDirectorSell2,500$60.50$151,250.00View SEC Filing  
12/8/2014Kenneth AronCTOSell2,000$56.68$113,360.00View SEC Filing  
11/25/2014Clinton SeversonCEOSell2,286$56.00$128,016.00View SEC Filing  
11/13/2014Clinton SeversonCEOSell10,000$55.00$550,000.00View SEC Filing  
11/5/2014Clinton SeversonCEOSell10,000$54.00$540,000.00View SEC Filing  
11/3/2014Alberto Santa InesCFOSell1,652$53.09$87,704.68View SEC Filing  
11/3/2014Clinton SeversonCEOSell5,000$53.00$265,000.00View SEC Filing  
10/31/2014Clinton SeversonCEOSell10,000$51.50$515,000.00View SEC Filing  
8/12/2014Richard BastianiDirectorSell1,000$45.40$45,400.00View SEC Filing  
7/30/2014Alberto Santa InesCFOSell10,738$47.81$513,383.78View SEC Filing  
7/29/2014Alberto Santa InesCFOSell17,293$48.01$830,236.93View SEC Filing  
6/5/2014Richard BastianiDirectorSell2,000$42.10$84,200.00View SEC Filing  
6/3/2014Richard BastianiDirectorSell4,000$41.88$167,520.00View SEC Filing  
5/22/2014Achim HenkelDirectorSell8,500$41.63$353,855.00View SEC Filing  
5/14/2014Henk EvenhuisDirectorSell4,000$44.06$176,240.00View SEC Filing  
5/1/2014Henk EvenhuisDirectorSell4,500$41.00$184,500.00View SEC Filing  
3/4/2014Vladimir OstoichVPSell9,800$38.53$377,594.00View SEC Filing  
2/24/2014Kenneth AronCTOSell1,000$38.98$38,980.00View SEC Filing  
2/13/2014Donald Peter WoodCOOSell8,864$38.50$341,264.00View SEC Filing  
6/7/2013Clinton SeversonCEOSell10,000$44.50$445,000.00View SEC Filing  
6/7/2013Martin MulroyInsiderSell14,000$44.80$627,200.00View SEC Filing  
5/22/2013Kenneth AronCTOSell4,200$43.28$181,776.00View SEC Filing  
5/7/2013Achim HenkelDirectorSell5,000$44.07$220,350.00View SEC Filing  
3/1/2013Achim HenkelDirectorSell1,000$42.85$42,850.00View SEC Filing  
2/26/2013Martin MulroyInsiderSell12,000$41.84$502,080.00View SEC Filing  
2/5/2013Kenneth AronCTOSell40,000$44.13$1,765,200.00View SEC Filing  
2/4/2013Martin MulroyInsiderSell12,000$43.97$527,640.00View SEC Filing  
11/23/2012Richard BastianiDirectorSell5,000$36.60$183,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Abaxis (NASDAQ:ABAX)
News IconFuture of Global Biochemistry Analyser Market : 2015 – 2021 (NASDAQ:ABAX)
www.medgadget.com - February 21 at 3:33 PM
us.rd.yahoo.com logoABAXIS INC Financials (NASDAQ:ABAX)
us.rd.yahoo.com - February 17 at 6:50 PM
sbwire.com logoHome Diagnostics Market Deep Research Report Analysis, Forecast and Outlook 2025 (NASDAQ:ABAX)
www.sbwire.com - February 16 at 8:19 PM
News IconFarm Animal Diagnostics Global Market Trend, Research Approach, Data Analysis and Forecast to 2022 (NASDAQ:ABAX)
www.emailwire.com - February 16 at 8:19 PM
marketexclusive.com logoAnalyst Activity – Canaccord Genuity Reiterates Hold on ABAXIS (NASDAQ:ABAX) (NASDAQ:ABAX)
marketexclusive.com - February 16 at 8:19 PM
biz.yahoo.com logoABAXIS INC Files SEC form 10-Q, Quarterly Report (NASDAQ:ABAX)
biz.yahoo.com - February 9 at 8:15 PM
capitalcube.com logoETFs with exposure to ABAXIS, Inc. : February 2, 2017 (NASDAQ:ABAX)
www.capitalcube.com - February 2 at 3:15 PM
News IconCould Abaxis Inc (ABAX) Change Direction After This Multiple Top Chart Pattern (NASDAQ:ABAX)
randolphguide.com - January 31 at 8:19 PM
capitalcube.com logoABAXIS, Inc. :ABAX-US: Earnings Analysis: Q3, 2017 By the Numbers : January 30, 2017 (NASDAQ:ABAX)
www.capitalcube.com - January 30 at 3:25 PM
marketexclusive.com logoAnalyst Activity – Stifel Nicolaus Lowers Its Price Target On ABAXIS (NASDAQ:ABAX) to $48.00 (NASDAQ:ABAX)
marketexclusive.com - January 27 at 3:26 PM
finance.yahoo.com logoEdited Transcript of ABAX earnings conference call or presentation 26-Jan-17 9:15pm GMT (NASDAQ:ABAX)
finance.yahoo.com - January 27 at 3:26 PM
finance.yahoo.com logoAbaxis (ABAX) Q3 Bleak: Earnings In Line, Revenues Miss (NASDAQ:ABAX)
finance.yahoo.com - January 27 at 3:26 PM
finance.yahoo.com logoAbaxis Reports Financial Performance for the Third Quarter of Fiscal 2017 ... (NASDAQ:ABAX)
finance.yahoo.com - January 27 at 1:35 AM
streetinsider.com logoAbaxis (ABAX) Misses Q3 EPS by 1c (NASDAQ:ABAX)
www.streetinsider.com - January 27 at 1:35 AM
rttnews.com logoAbaxis Inc. Announces 14% Retreat In Q3 Bottom Line (NASDAQ:ABAX)
www.rttnews.com - January 27 at 1:35 AM
us.rd.yahoo.com logoAbaxis Reports Financial Performance for the Third Quarter of Fiscal 2017, Declares Quarterly Cash Dividend (NASDAQ:ABAX)
us.rd.yahoo.com - January 26 at 8:34 PM
us.rd.yahoo.com logo4:08 pm Abaxis misses by $0.01, reports revs in-line with 1/10/2016 pre-announcement (NASDAQ:ABAX)
us.rd.yahoo.com - January 26 at 8:34 PM
sg.finance.yahoo.com logoAbaxis meets 3Q profit forecasts (NASDAQ:ABAX)
sg.finance.yahoo.com - January 26 at 8:34 PM
biz.yahoo.com logoQ3 2017 Abaxis Inc Earnings Release - After Market Close (NASDAQ:ABAX)
biz.yahoo.com - January 26 at 3:29 PM
finance.yahoo.com logoMedical Product Stocks' Earnings on Jan 26: ABMD, BCR, ABAX (NASDAQ:ABAX)
finance.yahoo.com - January 25 at 3:17 PM
4-traders.com logoAbaxis Inc : quaterly earnings release (NASDAQ:ABAX)
www.4-traders.com - January 23 at 3:16 PM
capitalcube.com logoABAXIS, Inc. : ABAX-US: Dividend Analysis : December 01st, 2016 (record date) : By the numbers : January 23, 2017 (NASDAQ:ABAX)
www.capitalcube.com - January 23 at 3:16 PM
finance.yahoo.com logoAbaxis To Report Third Quarter Fiscal Year 2017 Financial Results On Thursday, January 26, 2017 (NASDAQ:ABAX)
finance.yahoo.com - January 19 at 3:19 PM
finance.yahoo.com logoNew Strong Sell Stocks for January 12th (NASDAQ:ABAX)
finance.yahoo.com - January 12 at 3:17 PM
rttnews.com logoAbaxis Inc. (ABAX) Fell To A 2-Month Low On Disappointing Q3 Forecast (NASDAQ:ABAX)
www.rttnews.com - January 11 at 3:17 PM
capitalcube.com logoABAXIS, Inc. breached its 50 day moving average in a Bearish Manner : ABAX-US : January 11, 2017 (NASDAQ:ABAX)
www.capitalcube.com - January 11 at 3:17 PM
reuters.com logoBRIEF-Abaxis reports sees Q3 revenue $52 million to $53 million (NASDAQ:ABAX)
www.reuters.com - January 10 at 8:25 PM
marketexclusive.com logoABAXIS, INC. (NASDAQ:ABAX) Files An 8-K Results of Operations and Financial Condition (NASDAQ:ABAX)
marketexclusive.com - January 10 at 8:25 PM
finance.yahoo.com logoAbaxis Reports Preliminary Financial Performance for the Third Quarter of Fiscal 2017 (NASDAQ:ABAX)
finance.yahoo.com - January 10 at 3:23 PM
biz.yahoo.com logoABAXIS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:ABAX)
biz.yahoo.com - January 10 at 3:23 PM
seekingalpha.com logoAbaxis sees flat revenue growth in FQ3 (NASDAQ:ABAX)
seekingalpha.com - January 10 at 7:18 AM
News IconPoint of Care Diagnostics Market Is Projected To Reach $20.9 Billion By 2024: Grand View Research, Inc. (NASDAQ:ABAX)
www.medgadget.com - January 9 at 8:29 PM
News IconRapid Medical Diagnostic kits Market is Expected to Witness a Remarkable Boost due to the Growing Prevalence of Diseases (NASDAQ:ABAX)
www.medgadget.com - January 7 at 3:15 PM
finance.yahoo.com logoAbaxis, Inc. to Present at the 35th Annual J.P. Morgan Healthcare Conference (NASDAQ:ABAX)
finance.yahoo.com - January 5 at 3:29 PM
News IconGlobal Companion Animal Diagnostics Market, By Product, Data Validation, Analysis and Forecast 2022 (NASDAQ:ABAX)
www.emailwire.com - January 4 at 8:18 PM
News IconFarm Animal Diagnostics Global Market Research Methodology, Research Scope Forecast 2022 (NASDAQ:ABAX)
www.emailwire.com - January 4 at 3:16 PM
capitalcube.com logoETFs with exposure to ABAXIS, Inc. : January 3, 2017 (NASDAQ:ABAX)
www.capitalcube.com - January 3 at 3:17 PM
News IconRapid Medical Diagnostic Kits Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast upto 2019 (NASDAQ:ABAX)
reports.pr-inside.com - December 30 at 3:15 PM
capitalcube.com logoABAXIS, Inc. :ABAX-US: Earnings Analysis: Q2, 2017 By the Numbers : December 30, 2016 (NASDAQ:ABAX)
www.capitalcube.com - December 30 at 3:15 PM
newsmaker.com.au logoVeterinary Molecular Diagnostics Market is Expected to Gain Popularity Across the Globe (NASDAQ:ABAX)
www.newsmaker.com.au - December 27 at 5:11 AM
capitalcube.com logoABAXIS, Inc. breached its 50 day moving average in a Bearish Manner : ABAX-US : December 23, 2016 (NASDAQ:ABAX)
www.capitalcube.com - December 23 at 3:16 PM
openpr.com logoVeterinary Hematology Analyzers Market Share and Forecast 2015 - 2023 (NASDAQ:ABAX)
www.openpr.com - December 22 at 1:31 AM
finance.yahoo.com logoPoint of Care (PoC) Lipid Test Market Size & Forecast By Instruments (Brand Market Sizing: Roche Reflotron, … (NASDAQ:ABAX)
finance.yahoo.com - December 20 at 8:11 PM
finance.yahoo.com logoNorth America Point Of Care (PoC) Diagnostics Market Analysis By Product, By End-Use And Segment Forecasts To 2024 (NASDAQ:ABAX)
finance.yahoo.com - December 17 at 3:15 PM
insidermonkey.com logoIs Abaxis Inc (ABAX) Worthy of Your Portfolio? (NASDAQ:ABAX)
www.insidermonkey.com - December 13 at 3:18 PM
News IconAbaxis Inc. (ABAX) Insider Sells $255450.00 in Stock (NASDAQ:ABAX)
canalcncarauca.com - December 13 at 1:20 AM
streetinsider.com logoForm 4 ABAXIS INC For: Dec 05 Filed by: SEVERSON CLINTON (NASDAQ:ABAX)
www.streetinsider.com - December 8 at 1:41 AM
News IconInsiders Don’t Lie: Why Clinton Severson Sold 15,000 Shares of Abaxis Inc (NASDAQ:ABAX)? (NASDAQ:ABAX)
www.whatsonthorold.com - December 8 at 1:41 AM
capitalcube.com logoABAXIS, Inc. – Value Analysis (NASDAQ:ABAX) : December 6, 2016 (NASDAQ:ABAX)
www.capitalcube.com - December 6 at 3:18 PM
finance.yahoo.com logoNew Strong Sell Stocks for December 6th (NASDAQ:ABAX)
finance.yahoo.com - December 6 at 8:29 AM


What is Abaxis' stock symbol?

Abaxis trades on the NASDAQ under the ticker symbol "ABAX."

How often does Abaxis pay dividends? What is the dividend yield for Abaxis?

Abaxis declared a quarterly dividend on Thursday, January 26th. Investors of record on Wednesday, March 1st will be given a dividend of $0.14 per share on Wednesday, March 15th. This represents a $0.56 annualized dividend and a yield of 1.12%. The ex-dividend date is Monday, February 27th.

Where is Abaxis' stock going? Where will Abaxis' stock price be in 2017?

7 brokers have issued 12-month price objectives for Abaxis' shares. Their forecasts range from $39.00 to $48.00. On average, they anticipate Abaxis' share price to reach $45.00 in the next twelve months.

When will Abaxis announce their earnings?

Abaxis is scheduled to release their next quarterly earnings announcement on Wednesday, April, 26th 2017.

Who owns Abaxis stock?

Abaxis' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Brown Capital Management LLC (16.70%), Dimensional Fund Advisors LP (2.82%), State Street Corp (2.30%), Fred Alger Management Inc. (1.26%), Champlain Investment Partners LLC (0.78%) and Renaissance Technologies LLC (0.58%). Company insiders that own Abaxis stock include Achim Henkel, Clinton Severson, Craig Tockman, Donald Peter Wood, Henk Evenhuis, Kenneth Aron, Prithipal Singh, Richard Bastiani and Vernon E Altman.

Who sold Abaxis stock? Who is selling Abaxis stock?

Abaxis' stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Paradigm Asset Management Co. LLC, Fred Alger Management Inc., Brown Capital Management LLC, Champlain Investment Partners LLC, Pacific Global Investment Management CO, Menta Capital LLC and Bard Associates Inc.. Company insiders that have sold Abaxis stock in the last year include Achim Henkel, Clinton Severson, Donald Peter Wood, Henk Evenhuis, Kenneth Aron, Prithipal Singh and Richard Bastiani.

Who bought Abaxis stock? Who is buying Abaxis stock?

Abaxis' stock was purchased by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Dimensional Fund Advisors LP, State Street Corp, Elkfork Partners LLC, Tyers Asset Management LLC, Teachers Retirement System of The State of Kentucky, Pacad Investment Ltd. and Comerica Bank.

How do I buy Abaxis stock?

Shares of Abaxis can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Abaxis stock cost?

One share of Abaxis stock can currently be purchased for approximately $49.80.

Abaxis (NASDAQ:ABAX) Chart for Thursday, February, 23, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Abaxis (NASDAQ:ABAX)

Earnings History Chart

Earnings by Quarter for Abaxis (NASDAQ:ABAX)

Dividend History Chart

Dividend Payments by Quarter for Abaxis (NASDAQ:ABAX)

Last Updated on 2/23/2017 by MarketBeat.com Staff